NABP 2024-2025 Executive Committee Inaugurated at Association’s 120th Annual Meeting

Posted by

Icon of scale representing regulatory news

Delegates to the 120th National Association of Boards of Pharmacy® (NABP®) Annual Meeting, held in Fort Worth, TX, from May 14-17, 2024, elected individuals to fill the president-elect, treasurer, and open member positions on the Association’s 2024-2025 Executive Committee. The newly elected officers and members of the NABP Executive Committee are:  The following NABP Executive […]

Read More ›

Delegates Approve Four Resolutions at the 120th NABP Annual Meeting

Posted by

Icon of scale representing regulatory news

Delegates from the member boards of pharmacy adopted four resolutions during the 120th National Association of Boards of Pharmacy® (NABP®) Annual Meeting, held in Fort Worth, TX, on May 14-17, 2024. The resolutions address the following: Additionally, a recognition resolution honoring members of the Association who have passed away was unanimously approved. The complete text […]

Read More ›

NABP Announces 2024 Leadership Award Recipients

Posted by

Icon of scale representing regulatory news

The National Association of Boards of Pharmacy® (NABP®) has announced the recipients of the 2024 NABP Leadership Awards. Each year, the Association presents awards to individuals who have worked with unwavering dedication to ensure NABP’s continued service to the regulation of pharmacy practice and to the state boards of pharmacy in protecting public health. This […]

Read More ›

Recognition Resolution (119-6-23)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 119-6-23TITLE: Recognition ResolutionACTION: PASS WHEREAS, the individuals listed here have made significant contributions to NABP, the protection of public health, and the practice of pharmacy: Past President Gary A. Schnabel (OR)Past President Hal Wand (AZ)Past Honorary President Joseph A. Whaley, Jr (GA)Past Honorary President Donald H. Williams (WA)Edward R. “Eddie” Braden (AL)Leo “Lee” Fallon […]

Read More ›

Create an Industry Standard for Pharmacy Technician Scope of Practice and Entry-Level Requirements to Support Interstate Portability (Resolution 119-5-23)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 119-5-23TITLE: Create an Industry Standard for Pharmacy Technician Scope of Practice and Entry-Level Requirements to Support Interstate PortabilityACTION: PASS WHEREAS, on January 31, 2020, the Secretary of the United States Department of Health and Human Services issued a Public Readiness and Emergency Preparedness Act (PREP Act) Declaration in addition to guidelines and numerous […]

Read More ›

Expanding Pharmacy Technician Seats on State Boards of Pharmacy (Resolution 119-4-23)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 119-4-23TITLE: Expanding Pharmacy Technician Seats on State Boards of PharmacyACTION: PASS WHEREAS, in 2007, the Wyoming State Board of Pharmacy was the first to add a pharmacy technician member to serve on the Board; and WHEREAS, since 2007, Arizona, Illinois, Iowa, Massachusetts, Michigan, Montana, North Dakota, Oregon, Rhode Island, Texas, Utah, Vermont, and […]

Read More ›

Increasing Access to Medications for Opioid Use Disorder (Resolution 119-3-23)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 119-3-23TITLE: Increasing Access to Medications for Opioid Use DisorderACTION: PASS WHEREAS, opioid use disorder (OUD) continues to grow to epidemic proportions in the United States, with an estimated 3 million people suffering from OUD in 2021;1 and WHEREAS, also in 2021, nearly 108,000 people died from drug overdoses, with approximately 81,000 of those […]

Read More ›

Drug Supply Chain Security Act Education and Compliance Assessment (Resolution 119-2-23)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 119-2-23TITLE: Drug Supply Chain Security Act Education and Compliance AssessmentACTION: PASS WHEREAS, suspect products, as defined by Title II Drug Supply Chain Security Act (DSCSA) of the Drug Quality and Security Act (DQSA), pose a significant risk to patient safety; andWHEREAS, suspect products, as defined by Title II Drug Supply Chain Security Act […]

Read More ›

Point-of-Care Testing and Treatment by Pharmacists (Resolution 119-1-23)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 119-1-23TITLE: Point-of-Care Testing and Treatment by PharmacistsACTION: PASS WHEREAS, pharmacists, as highly accessible health care providers, have played a vital role in the public health response to the coronavirus disease 2019 (COVID-19) pandemic; and WHEREAS, the COVID-19 pandemic and related emergency declarations allowed for an expanded scope of practice for pharmacists, allowing them […]

Read More ›

2023 Report of the Incoming President

Posted by

Icon of scale representing regulatory news

Lenora S. Newsome, PD, presented the Report of the Incoming President during the 119th Annual Meeting: Good afternoon! I have truly enjoyed meeting so many new colleagues and seeing old friends over the past few days here in Nashville. I hope you have learned something new, made a new connection, or been inspired by something […]

Read More ›
Page 1 of 25
1 2 3 25